Regulatory leadership RCA operates with a deep bench of experts in FDA-regulated industries and is widely recognized for resolving complex regulatory challenges, presenting opportunities to position RCA as a strategic partner for companies facing major compliance hurdles or impending agency actions.

Acquisitions & growth Past acquisition by Sotera Health and leadership expansions signal a growth trajectory and potential cross-sell opportunities with broader life sciences networks, enabling a sales approach that emphasizes scalable quality and regulatory programs across portfolio companies.

Executive access Recent leadership hires and senior EVP appointments in Pharmaceuticals create entry points for enterprise deals and long-term engagements, suggesting a path to target large pharma and device manufacturers seeking senior-level regulatory strategy and program leadership.

Global collaboration Partnership activities with Compliance Academy and international regulatory thought networks indicate RCA’s capability to support global clients with harmonized quality and regulatory programs, opening doors to multinational organizations seeking cross-border compliance solutions.

Growth-ready services A broad service offering spanning quality, regulatory, operations and R&D, plus a proven approach to remediation, warning letters and consent decrees, positions RCA to upsell comprehensive compliance programs to mid-market and high-growth life sciences companies undergoing rapid expansion.